cardiometabolic

CureusEffects of Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors on Lipid Profiles in Type 2 Diabetes: A Systematic ReviewSodium glucose cotransporter 2 (SGLT2) inhibitors provide cardiometabolic benefits in adults with type 2 diabetes mellitus,….1 day ago

News Source074 views

CureusEffects of Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors on Lipid Profiles in Type 2 Diabetes: A Systematic ReviewSodium glucose cotransporter 2 (SGLT2) inhibitors provide cardiometabolic benefits in adults with type…

Read more

Effects of an anti-lipogenic low-carbohydrate high polyunsaturated fat diet or a healthy Nordic diet versus usual care on liver fat and cardiometabolic disorders in type 2 diabetes or prediabetes: a randomized controlled trial (NAFLDiet)

Fredrik Rosqvist0129 views

The Ethical Review Board of Sweden approved the study and all participants signed a written informed consent prior to inclusion (Dnr: 2019-05111 and 2020-05470). Metabolic-dysfunction Associated Steatotic Liver Disease (MASLD)…

Read more

The Cureus Journal of Medical ScienceCardiometabolic Benefits and Risks of Sodium-Glucose Co-Transporter-2 (SGLT-2) Inhibitor and Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Combination Therapy in Type 2 Diabetes: A Systematic ReviewType 2 diabetes (T2DM) management increasingly focuses on cardiometabolic protection. Sodium-glucose co-transporter-2 inhibitors (SGLT2is)….1 day ago

News Source0186 views

The Cureus Journal of Medical ScienceCardiometabolic Benefits and Risks of Sodium-Glucose Co-Transporter-2 (SGLT-2) Inhibitor and Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Combination Therapy in Type 2 Diabetes: A Systematic ReviewType 2…

Read more